Candel Therapeutics added Martine Zimmermann to its Board of Directors and shared details about her pay and experience.

Sep 10, 2026, 8:20 AM ETNew bossRead the original at sec.gov

Good for CADL

Candel appointed Martine Zimmermann and expanded the board to 11 members; her regulatory leadership and global agency experience should help the company's drug-development interactions.

CADL · Candel Therapeutics, Inc.

AI read · Good for CADL

The AI's read

Candel Therapeutics appointed Martine Zimmermann to its board and expanded the board from 10 to 11 members. She brings senior regulatory experience with FDA, EMA and Japanese regulators, which should strengthen the company's regulatory capabilities.

Get alerts for CADL

Follow Candel Therapeutics, Inc. (CADL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CADL

Free on the App Store and Google Play, or on the web.